↓ Skip to main content

Addition of intravenous beta2-agonists to inhaled beta2-agonists for acute asthma

Overview of attention for article published in Cochrane database of systematic reviews, December 2012
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (95th percentile)
  • Good Attention Score compared to outputs of the same age and source (76th percentile)

Mentioned by

blogs
3 blogs
twitter
11 tweeters
facebook
1 Facebook page
wikipedia
1 Wikipedia page

Citations

dimensions_citation
60 Dimensions

Readers on

mendeley
155 Mendeley
citeulike
1 CiteULike
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Addition of intravenous beta2-agonists to inhaled beta2-agonists for acute asthma
Published in
Cochrane database of systematic reviews, December 2012
DOI 10.1002/14651858.cd010179
Pubmed ID
Authors

Andrew H Travers, Stephen J Milan, Arthur P Jones, Carlos A Camargo Jr, Brian H Rowe

Abstract

Inhaled beta-agonist therapy is central to the management of acute asthma. This review evaluates the benefit of an additional use of intravenous beta(2)-agonist agents.

Twitter Demographics

The data shown below were collected from the profiles of 11 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 155 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 2 1%
Denmark 1 <1%
Unknown 152 98%

Demographic breakdown

Readers by professional status Count As %
Student > Master 30 19%
Researcher 23 15%
Other 17 11%
Student > Bachelor 16 10%
Student > Postgraduate 11 7%
Other 26 17%
Unknown 32 21%
Readers by discipline Count As %
Medicine and Dentistry 79 51%
Nursing and Health Professions 10 6%
Pharmacology, Toxicology and Pharmaceutical Science 8 5%
Social Sciences 7 5%
Agricultural and Biological Sciences 3 2%
Other 9 6%
Unknown 39 25%

Attention Score in Context

This research output has an Altmetric Attention Score of 26. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 May 2018.
All research outputs
#927,982
of 17,406,316 outputs
Outputs from Cochrane database of systematic reviews
#2,445
of 11,674 outputs
Outputs of similar age
#11,519
of 263,440 outputs
Outputs of similar age from Cochrane database of systematic reviews
#118
of 488 outputs
Altmetric has tracked 17,406,316 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,674 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 25.1. This one has done well, scoring higher than 79% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 263,440 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 488 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 76% of its contemporaries.